Grandfield & Dodd, LLC Incyte Corp Transaction History

Grandfield & Dodd, LLC

$1.5 Billion
Q1 2024

A detailed history of Grandfield & Dodd, LLC transactions in Incyte Corp stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 18,810 shares of INCY stock, worth $1.24 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

18,810

Previous 18,390 2.28%

Holding current value

$1.24 Million

Previous $1.15 Million 7.19%

% of portfolio

0.07%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$56.55 - $66.59 $23,751 - $27,967	420 Added 2.28%	18,810 $1.07 Million
Q4 2023 Jan 31, 2024	BUY	$52.16 - $64.19 $16,639 - $20,476	319 Added 1.77%	18,390 $1.15 Million
Q3 2023 Oct 25, 2023	BUY	$57.77 - $65.93 $26,863 - $30,657	465 Added 2.64%	18,071 $1.04 Million
Q2 2023 Aug 07, 2023	BUY	$60.95 - $75.51 $12,860 - $15,932	211 Added 1.21%	17,606 $1.1 Million
Q1 2023 Apr 28, 2023	BUY	$70.23 - $86.01 $24,931 - $30,533	355 Added 2.08%	17,395 $1.26 Million

Q4 2022 Jan 20, 2023	BUY	$67.18 - $84.11 $75,577 - $94,623	1,125 Added 7.07%	17,040 $0
Q3 2022 Nov 03, 2022	BUY	$66.18 - $82.86 $23,163 - $29,001	350 Added 2.25%	15,915 $1.06 Million
Q2 2022 Aug 01, 2022	BUY	$66.18 - $83.18 $12,243 - $15,388	185 Added 1.2%	15,565 $1.18 Million
Q1 2022 Apr 19, 2022	BUY	$66.02 - $79.71 $31,029 - $37,463	470 Added 3.15%	15,380 $1.22 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $112,111 - $131,174	1,770 Added 13.47%	14,910 $1.09 Million
Q3 2021 Oct 28, 2021	BUY	$68.67 - $84.02 $19,227 - $23,525	280 Added 2.18%	13,140 $900,000
Q2 2021 Jul 28, 2021	BUY	$79.87 - $87.53 $17,172 - $18,818	215 Added 1.7%	12,860 $1.08 Million
Q1 2021 Apr 22, 2021	BUY	$76.02 - $100.5 $8,362 - $11,055	110 Added 0.88%	12,645 $1.03 Million
Q4 2020 Jan 29, 2021	BUY	$80.74 - $97.7 $28,985 - $35,074	359 Added 2.95%	12,535 $1.09 Million
Q3 2020 Nov 03, 2020	BUY	$85.07 - $109.69 $18,970 - $24,460	223 Added 1.87%	12,176 $1.09 Million
Q2 2020 Jul 24, 2020	BUY	$74.18 - $108.93 $56,376 - $82,786	760 Added 6.79%	11,953 $1.24 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $35,886 - $48,830	568 Added 5.35%	11,193 $820,000
Q4 2019 Feb 07, 2020	BUY	$73.04 - $95.72 $64,640 - $84,712	885 Added 9.09%	10,625 $928,000
Q3 2019 Oct 30, 2019	BUY	$72.82 - $86.52 $61,532 - $73,109	845 Added 9.5%	9,740 $723,000
Q2 2019 Jul 29, 2019	BUY	$73.52 - $88.7 $47,935 - $57,832	652 Added 7.91%	8,895 $756,000
Q1 2019 Apr 26, 2019	BUY	$63.56 - $88.17 $6,737 - $9,346	106 Added 1.3%	8,243 $709,000
Q4 2018 Feb 12, 2019	BUY	$58.5 - $69.94 $9,886 - $11,819	169 Added 2.12%	8,137 $517,000
Q3 2018 Nov 02, 2018	BUY	$61.75 - $74.23 $4,631 - $5,567	75 Added 0.95%	7,968 $550,000
Q2 2018 Jul 27, 2018	BUY	$60.85 - $83.98 $4,259 - $5,878	70 Added 0.89%	7,893 $529,000
Q1 2018 May 04, 2018	SELL	$83.06 - $100.98 $9,967 - $12,117	-120 Reduced 1.51%	7,823 $652,000
Q4 2017 Feb 06, 2018	BUY	$93.56 - $116.6 $13,566 - $16,907	145 Added 1.86%	7,943 $752,000
Q3 2017 Nov 03, 2017	BUY	$109.15 - $138.27 $851,151 - $1.08 Million	7,798	7,798 $910,000

Others Institutions Holding INCY

# of Institutions

619

Shares Held

215M

Call Options Held

366K

Put Options Held

445K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Account

Grandfield & Dodd, LLC Incyte Corp Transaction History